Trulicity (DULAGLUTIDE)
Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high sugar levels (such as after a meal) and by decreasing the amount of sugar your liver makes. Inject this medication under the skin in the thigh, abdomen, or upper arm as directed by your doctor, usually once every 7 days. Do not inject into a vein or muscle. It may be used with or without meals.

If you are also using insulin, give dulaglutide and insulin as separate injections. Do not mix them. You may inject these medications in the same area of the body, but the injection sites should not be next to each other.

trulicity
Indications and Usage

TRULICITY is a glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitations of Use:

  • Not recommended as first-line therapy for patients inadequately controlled on diet and exercise
  • Has not been studied in patients with a history of pancreatitis.
  • Consider another antidiabetic therapy
  • Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
  • Not for patients with pre-existing severe gastrointestinal disease.
  • Has not been studied in combination with basal insulin


Dosage

The recommended initiating dose of TRULICITY is 0.75 mg once weekly. The dose may be increased to 1.5 mg once weekly for additional glycemic control. The maximum recommended dose is 1.5 mg once weekly.

Administer TRULICITY once weekly, any time of day, with or without food. TRULICITY should be injected subcutaneously in the abdomen, thigh, or upper arm.

If a dose is missed, instruct patients to administer as soon as possible if there are at least 3 days (72 hours) until the next scheduled dose. If less than 3 days remain before the next scheduled dose, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.

The day of weekly administration can be changed if necessary as long as the last dose was administered 3 or more days before


DOSAGE FORMS, AND STRENGHTS

Injection: 0.75 mg/0.5 mL or solution in a single-dose pen
Injection: 1.5 mg/0.5 mL solution in a single-dose pen
Injection: 0.75 mg/0.5 mL solution in a single-dose prefilled syringe
Injection: 1.5 mg/0.5 mL solution in a single-dose prefilled syringe

POSSIBLE SIDE EFFECTS

Nausea, diarrhea, vomiting, abdominal pain, stomach upset, decreased appetite, tiredness, or weakness may occur. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.

Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor right away if you have any serious side effects, including: slow/ irregular heartbeat, change in the amount of urine.

Persistent vomiting/diarrhea may result in a serious loss of body water


CONTRAINDICATIONS

TRULICITY is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2

TRULICITY is contraindicated in patients with a prior serious hypersensitivity reaction to TRULICITY or any of the product components